Atara Biotherapeutics, Inc.;The Council of the Queensland Institute of Medical Research
发明人:
Khanna, Rajiv,Smith, Corey,Aftab, Blake Tolu
申请号：
AU2018210375
公开号：
AU2018210375A1
申请日:
2018.01.19
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided herein are methods comprising autologous cytotoxic T cells expressing a T cell receptor that specifically binds to an Epstein Barr virus (EBV) or expressing CD107a, TNF, IFN-gamma or IL-2 for the treatment of multiple sclerosis in a subject or selecting a subject for adoptive immunotherapy.
